AstraZeneca ADR Earnings, Revenue beat In Q1

  • Investing.com
AstraZeneca ADR Earnings, Revenue beat In Q1

Investing.com - AstraZeneca (LON: AZN ) ADR reported first quarter earnings that beat analysts' expectations on Friday and revenue that topped forecasts.

The firm reported earnings per share of $1.89 on revenue of $11.39B. Analysts polled by Investing.com anticipated EPS of $0.8258 on revenue of $10.74B. .

For the year, AstraZeneca ADR shares are up 15.4%, outperforming the Nasdaq 100 which is down 17.55% year to date.

AstraZeneca ADR follows other major Healthcare sector earnings this month


On Thursday, April 14, 2022, UnitedHealth reported first quarter EPS of $5.49 on revenue of $80.15B, compared to forecasts of EPS of $5.36 on revenue of $78.73B.

J&J earnings beat analyst's expectations on Tuesday, April 19, 2022, with first quarter EPS of $2.67 on revenue of $23.43B. Investing.com analysts expected EPS of $2.59 on revenue of $23.62B

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100